[go: up one dir, main page]

GB0406450D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0406450D0
GB0406450D0 GB0406450A GB0406450A GB0406450D0 GB 0406450 D0 GB0406450 D0 GB 0406450D0 GB 0406450 A GB0406450 A GB 0406450A GB 0406450 A GB0406450 A GB 0406450A GB 0406450 D0 GB0406450 D0 GB 0406450D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0406450A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0406450A priority Critical patent/GB0406450D0/en
Publication of GB0406450D0 publication Critical patent/GB0406450D0/en
Priority to BRPI0508959-0A priority patent/BRPI0508959A/en
Priority to JP2007504466A priority patent/JP2007530517A/en
Priority to NZ549552A priority patent/NZ549552A/en
Priority to KR1020067021797A priority patent/KR20060130764A/en
Priority to CA002558346A priority patent/CA2558346A1/en
Priority to CNA2005800092178A priority patent/CN101242826A/en
Priority to AU2005225192A priority patent/AU2005225192B2/en
Priority to EP05729384A priority patent/EP1740170A2/en
Priority to PCT/GB2005/001079 priority patent/WO2005092384A2/en
Priority to MXPA06010755A priority patent/MXPA06010755A/en
Priority to US10/594,235 priority patent/US20080113039A1/en
Priority to IL177951A priority patent/IL177951A0/en
Priority to ZA200607550A priority patent/ZA200607550B/en
Priority to NO20064753A priority patent/NO20064753L/en
Priority to US12/951,902 priority patent/US20110256240A1/en
Ceased legal-status Critical Current

Links

GB0406450A 2004-03-23 2004-03-23 Combination therapy Ceased GB0406450D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0406450A GB0406450D0 (en) 2004-03-23 2004-03-23 Combination therapy
US10/594,235 US20080113039A1 (en) 2004-03-23 2005-03-22 Combination Therapy
CNA2005800092178A CN101242826A (en) 2004-03-23 2005-03-22 Combination therapy using AZD2171 and platinum anti-tumor agent
EP05729384A EP1740170A2 (en) 2004-03-23 2005-03-22 Combination therapy with azd2171 and platinum anti-tumour agent
NZ549552A NZ549552A (en) 2004-03-23 2005-03-22 Combination therapy involving 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline (AZD2171) and a platinum anti-tumour agent
KR1020067021797A KR20060130764A (en) 2004-03-23 2005-03-22 Combination therapy
CA002558346A CA2558346A1 (en) 2004-03-23 2005-03-22 Combination therapy
BRPI0508959-0A BRPI0508959A (en) 2004-03-23 2005-03-22 use of azd2171 or a pharmaceutically acceptable salt of the same, use of azd2171 maleate salt and oxaliplatin, pharmaceutical composition, kit, and method for producing an antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal
AU2005225192A AU2005225192B2 (en) 2004-03-23 2005-03-22 Combination therapy
JP2007504466A JP2007530517A (en) 2004-03-23 2005-03-22 Combination therapy
PCT/GB2005/001079 WO2005092384A2 (en) 2004-03-23 2005-03-22 Combination therapy with azd2171 and a platinum anti-tumour agent
MXPA06010755A MXPA06010755A (en) 2004-03-23 2005-03-22 Combination therapy.
IL177951A IL177951A0 (en) 2004-03-23 2006-09-07 Combination therapy including azd2171 and a platinum anticancer agent
ZA200607550A ZA200607550B (en) 2004-03-23 2006-09-08 Combination therapy
NO20064753A NO20064753L (en) 2004-03-23 2006-10-20 combination therapy
US12/951,902 US20110256240A1 (en) 2004-03-23 2010-11-22 Combination Therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0406450A GB0406450D0 (en) 2004-03-23 2004-03-23 Combination therapy

Publications (1)

Publication Number Publication Date
GB0406450D0 true GB0406450D0 (en) 2004-04-28

Family

ID=32188486

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0406450A Ceased GB0406450D0 (en) 2004-03-23 2004-03-23 Combination therapy

Country Status (3)

Country Link
CN (1) CN101242826A (en)
GB (1) GB0406450D0 (en)
ZA (1) ZA200607550B (en)

Also Published As

Publication number Publication date
CN101242826A (en) 2008-08-13
ZA200607550B (en) 2008-05-28

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
IL177155A0 (en) Therapeutic combinations
GB0403780D0 (en) Therapeutic agents
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
GB0504206D0 (en) Combination therapy
GB0424339D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
GB0417558D0 (en) Novel combination therapy
GB0518720D0 (en) Therapeutic combination
GB0400193D0 (en) Therapeutic agents
GB0421438D0 (en) Combination therapy
GB0421436D0 (en) Combination therapy
GB0406450D0 (en) Combination therapy
GB0424638D0 (en) Combination therapy
GB0407755D0 (en) Combination therapy
GB0407753D0 (en) Combination therapy
GB0406546D0 (en) Combination therapy
GB0400196D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0403779D0 (en) Therapeutic agents
GB0500658D0 (en) Combination therapy
GB0526132D0 (en) Combination Therapy
GB0526121D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)